financetom
Business
financetom
/
Business
/
Adaptive Biotechnologies Insider Sold Shares Worth $1,315,180, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Adaptive Biotechnologies Insider Sold Shares Worth $1,315,180, According to a Recent SEC Filing
Nov 13, 2025 1:13 AM

03:54 AM EST, 11/13/2025 (MT Newswires) -- Chad M Robins, Director, Chief Executive Officer and Chairman, on November 10, 2025, sold 89,265 shares in Adaptive Biotechnologies ( ADPT ) for $1,315,180. Following the Form 4 filing with the SEC, Robins has control over a total of 2,869,975 common shares of the company, with 2,869,975 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1478320/000178064925000002/xslF345X05/primary_doc.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chemtrade Logistics Income Fund Announces Closing of the Acquisition of Polytec, Inc.
Chemtrade Logistics Income Fund Announces Closing of the Acquisition of Polytec, Inc.
Nov 21, 2025
TORONTO--(BUSINESS WIRE)-- Chemtrade Logistics Income Fund (“Chemtrade” or the “Fund”) today announced that it has completed the previously announced acquisition of Polytec, Inc. (“Polytec”), a southeastern United States-based provider of turnkey water treatment solutions, for US$150 million. Chemtrade financed the transaction by drawing on its credit facility. The acquisition provides Chemtrade with a unique solutions platform that can be leveraged...
Sector Update: Consumer
Sector Update: Consumer
Nov 21, 2025
01:12 PM EST, 11/21/2025 (MT Newswires) -- Consumer stocks were rising Friday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) increasing 1.2% and the Consumer Discretionary Select Sector SPDR Fund (XLY) gaining 1.9%. In corporate news, Nike ( NKE ) may reemerge as a sneaker suitor for National Basketball Association star Stephen Curry following his split last week...
Shuttle Pharmaceuticals Acquires Molecule.ai
Shuttle Pharmaceuticals Acquires Molecule.ai
Nov 21, 2025
01:10 PM EST, 11/21/2025 (MT Newswires) -- Shuttle Pharmaceuticals ( SHPH ) said Friday it has finalized its purchase of Molecule.ai, a Canada-based artificial intelligence firm specializing in molecular discovery and drug development tools. A Shuttle unit acquired nearly all of Molecule.ai's assets and liabilities for a total purchase price of $8 million payable in cash and shares, plus as...
Form 8.3
Form 8.3
Nov 21, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Polaris Capital Management, LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Copyright 2023-2026 - www.financetom.com All Rights Reserved